Bio-Techne Corp (STU:TE1)
€ 69.5 0 (0%) Market Cap: 11.07 Bil Enterprise Value: 11.27 Bil PE Ratio: 80.74 PB Ratio: 5.63 GF Score: 95/100

Bio-Techne Corp at Stifel Healthcare Conference Transcript

Nov 19, 2019 / 06:50PM GMT
Release Date Price: €48.5 (+2.11%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Okay. Our next section -- session is going to be with Bio-Techne. We're happy to have Chuck Kummeth, the CEO here. I think we'll do a similar thing and that he'll spend a couple of minutes on some slides, and then we'll just go into Q&A right afterwards. Chuck, Thanks.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Thank you. Well, presentation, but probably too long for a chat. We're going to go really fast on these. So they're actually online too if you want this short deck. We loaded it today, I think, right? Okay. I should mention that we do have a -- this our new tagline, Dan, so where science intersects innovation.

So innovation pretty overused. Combined with science, maybe better, we'll see, but anyway after waiting a year and saying no to marketing 349 times, I had to give in on one. So this is us and headquarters, still Minneapolis, too many locations for our size. We're not really focused on cost

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot